CIP
SLXP

Chartwell Investment Partners’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Chartwell Investment Partners’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-68,495
Closed -$7.87M – 397
2014
Q4 		$7.87M Buy
68,495
+5,945
+10% +$720K 0.16% 226
2014
Q3 		$9.77M Sell
62,550
-475
-0.8% -$68.9K 0.22% 182
2014
Q2 		$7.77M Buy
+63,025
New +$6.97M 0.16% 206

Other funds holding SLXP

PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
YCMGA
York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Chartwell Investment Partners's SLXP Position: Q1 2015 in Review

Chartwell Investment Partners sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q1 2015, closing a stake of 68,495 shares — an estimated $7.87M sold.

Chartwell Investment Partners first reported a position in SLXP in Q2 2014 and held it in 3 quarters. The position peaked at $9.77M in Q3 2014. 298 funds tracked by Wall St. Rank hold SLXP as of Q1 2015.

  • Chartwell Investment Partners reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q1 2015 after selling out during the quarter.
  • Chartwell Investment Partners sold 68,495 SALIX PHARMACEUTICALS LTD DEL shares in Q1 2015, an estimated $7.87M.
  • Chartwell Investment Partners first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2014 and held it in 3 quarters.
  • Chartwell Investment Partners's SALIX PHARMACEUTICALS LTD DEL position peaked at $9.77M in Q3 2014.
  • 298 funds tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q1 2015.

Based on Chartwell Investment Partners's 13F filing for Q1 2015, filed 30 Apr 2015.